Nasonex – Medicinal Product Register of Latvia

Mometasoni furoas

Search by the name of the active substance

Return to the results

Medicinal product name

Nasonex 50 micrograms/dose nasal spray, suspension

Pharmaceutical form

Nasal spray, suspension

Strength

50 µg/dose

Information from the MAH on shortages

Not available
predicted availability date: May 20, 2024

Availability of medicinal product

Product No.	Package size	Wholesalers' stock state
00-0820-04	N140: 1 × 140	Is available

Legal status

Rx Prescription (Pr.)

Summary of product characteristics

02-09-2021

Package leaflet

28-03-2023

ATC code

R01AD09 – Nasal preparations

Information for Marketing authorisation holders

View

Package leaflet	28-03-2023

Medicinal products (4)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N60: 1 × 60 (50 µg/dose)	HDPE bottle		00-0820-03	Labelling text Sep 2, 2021
Is available (according to the information provided by wholesalers) (222 containers) predicted availability date: May 20, 2024	Baltfarm "Vita-Farm", Oribalt Rīga, Medelens+	N140: 1 × 140 (50 µg/dose)	HDPE bottle	€ 12.99	00-0820-04	Labelling text Sep 2, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N280: 2 × 140 (50 µg/dose)	HDPE bottle		00-0820-05	Labelling text Sep 2, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N420: 3 × 140 (50 µg/dose)	HDPE bottle		00-0820-06	Labelling text Sep 2, 2021

Registration information

Marketing authorisation No.	00-0820
Date of authorisation	Sep 6, 2000
Marketing authorisation holder, country	N.V. Organon, Netherlands

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 19, 2024.